EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design of Experiments (DoE)‐Optimized Polymeric Oxytocin Nanoparticles for Enhanced Nose‐to‐Brain Delivery

Naveed Ahmad, Shunping Han, Rifka Utami, Rafal Baker, Dina Helal, Zhuoni Li, Mark Tricklebank, Yannis Paloyelis iD, Julie Wang, Marija M Petrinovic iD, Sukhi Bansal, Khuloud T Al-Jamal iD

Small · 2026

DOI: 10.1002/smll.202511603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Naveed Ahmad und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Science, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK. Hauptthemen laut MEDLINE: Oxytocin, Nanoparticles, Brain, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Brain Research UK, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxytocin (OT) is a promising candidate for regulating social behavior in autism spectrum disorder (ASD). However, its inconsistent efficacy can be attributed to the lack of an efficient delivery system that selectively target the brain without inducing peripheral side effects following intranasal (IN) administration. In this study, OT is encapsulated within an FDA‐approved poly (lactic‐co‐glycolic acid) (PLGA) nanoparticles (OT‐NP) to improve nose‐to‐brain (NTB) delivery. A PEGylated version (OT‐NP‐PEG) is developed to improve nasal mucosal diffusion. Optimization using a design of experiments (DoE) approach produced nanoparticles with hydrodynamic diameters of ≈93–116 nm, polydispersity index ≈0.20, zeta potential –21 to –33 mV, and drug loading ≈2.8–3.5% (w/w). The stable OT‐NP‐PEG showed sustained release (>42% and 58% at 24 and 72 h) and greater diffusion through simulated nasal mucus. [ 14 C] OT is synthesized with chemical and radiochemical yields of 74% and 53%, respectively. Following IN administration in mice, [ 14 C] OT‐NP‐PEG demonstrated rapid brain uptake, particularly in the olfactory bulb and frontal cortex, with reduced blood and liver exposure compared with free [ 14 C] OT. Finally, IN OT‐NP‐PEG significantly increased self‐grooming frequency in mice, indicating maintained bioactivity and behavioral effects. Overall, OT‐NP‐PEG offers a rationally designed nanoplatform for brain‐targeted OT delivery in ASD and other neuropsychiatric disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxytocinNanoparticlesBrainDrug Delivery SystemsPolymersAnimalsAdministration, IntranasalMiceNasal MucosaPolyethylene Glycols

Stichwörter der Autor:innen

PLGAartificial intelligenceautismautoradiographyencapsulationpeptideradiolabeling

Substanzen

OxytocinPolymersPolyethylene Glycols

Autor:innen und Institutionen

  • Institute of Pharmaceutical Science, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
  • Faculty of Pharmacy, Hasanuddin University, Makassar, 90245, Indonesia.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Monazzamet El Wehda El Afrikeya Street, Abbasseya, Cairo, Egypt.
  • Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.
  • Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK.
  • Medical Research Council Centre for Neurodevelopmental Disorders, King's College London, New Hunt's House, London, SE1 1UL, UK.

ORCID-Profile: Yannis Paloyelis, Marija M Petrinovic, Khuloud T Al-Jamal

Förderung

  • Wellcome Trust
  • Brain Research UK
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Ahmad, N., Han, S., Utami, R., Baker, R., Helal, D., Li, Z., Tricklebank, M., Paloyelis, Y., Wang, J., Petrinovic, M. M., Bansal, S., & Al-Jamal, K. T. (2026). Design of Experiments (DoE)‐Optimized Polymeric Oxytocin Nanoparticles for Enhanced Nose‐to‐Brain Delivery. Small. https://doi.org/10.1002/smll.202511603

Vancouver

Ahmad N, Han S, Utami R, Baker R, Helal D, Li Z, et al. Design of Experiments (DoE)‐Optimized Polymeric Oxytocin Nanoparticles for Enhanced Nose‐to‐Brain Delivery. Small. 2026. doi:10.1002/smll.202511603

BibTeX
@article{Ahmad2026,
  author = {Ahmad, Naveed and Han, Shunping and Utami, Rifka and Baker, Rafal and Helal, Dina and Li, Zhuoni and Tricklebank, Mark and Paloyelis, Yannis and Wang, Julie and Petrinovic, Marija M and Bansal, Sukhi and Al-Jamal, Khuloud T},
  title = {Design of Experiments (DoE)‐Optimized Polymeric Oxytocin Nanoparticles for Enhanced Nose‐to‐Brain Delivery},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.202511603}
}
Kostenlos starten →